<DOC>
	<DOCNO>NCT01692691</DOCNO>
	<brief_summary>The purpose study determine whether dacarbazine carmustine dose schedule use study help increase tumor shrinkage .</brief_summary>
	<brief_title>Dacarbazine Carmustine Metastatic Melanoma</brief_title>
	<detailed_description>In phase II trial , patient stage IV melanoma treat dacarbazine carmustine commonly use cancer , give use schedule might theoretically improve combination . Patients study assessed term toxicity , response rate , median duration response , median time disease progression , median survival .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>1 . Patients must histologicallyproven diagnosis metastatic malignant melanoma progress least one prior systemic therapy . 2 . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 estimate survival least 3 month . 3 . Patients must felt recovered effect prior cancer therapy , past expect leukocyte nadir chemotherapy ( &gt; 2 week ) . 4 . Absolute granulocyte count least 1500/mm3 ; hemoglobin least 9 gm/dl ; platelet count least 100,000/mm3 ; bilirubin must less 1.5 mg/dl ; ALT AST must less 3 time upper limit normal ; creatinine must less equal 1.8 mg/dl . 5 . Women childbearing potential must negative pregnancy test adequate precaution prevent pregnancy treatment must take . 6 . Patient consent must obtain prior entrance onto study . 7 . Patients must evidence significant cardiovascular disease include history recent ( &lt; 6 month ) myocardial infarction , uncompensated congestive heart failure , uncontrolled angina cerebrovascular accident . 1 . Evidence significant cardiovascular disease include history recent ( &lt; 6 month ) myocardial infarction , uncompensated congestive heart failure , uncontrolled angina , cerebrovascular accident . 2 . Prior history psychiatric disorder could exacerbate could preclude completion therapy . 3 . Pregnancy lactation . 4 . Prior chemotherapy carmustine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Melanoma Metastatic</keyword>
</DOC>